Post Categories
Novel Coronavirus Testing: Part IV
May 18, 2020
Saliva Testing Accurate, rapid testing for the novel coronavirus (SARS-CoV-2) is crucial to controlling the COVID-19 pandemic. In previous installments of this blog series,…
Novel Coronavirus Testing: Part III
May 6, 2020
Antigen Testing Part I of this series on testing for the novel coronavirus covered the real-time reverse transcription polymerase chain reaction (rRT-PCR) assay, which…
Airborne Coronavirus Discovered in China – Could It Transmit the Novel Coronavirus?
May 6, 2020
Earlier this week, we discussed an aerosolized droplet study conducted by the University of Pennsylvania Perelman School of Medicine and the National Institutes of…
Aerosolized Droplet Study
April 29, 2020
Can the Novel Coronavirus Spread Through Speaking? There are conflicting opinions on whether the novel coronavirus, the virus that causes COVID-19, can be spread…
Novel Coronavirus Testing: Part II
April 27, 2020
Serology Testing “Test, test, test,” was the singular message from the World Health Organization’s Director-General Tedros Adhanom Ghebreyesus during remarks on the coronavirus pandemic…
Novel Coronavirus Testing: Part I
April 20, 2020
Real-Time Reverse Transcriptase Polymerase Chain Reaction Testing is the crucial first step to identifying and treating COVID-19. In the past few months, uncertainty has…
Clinical Trials: Coronavirus Impact and FDA Guidelines
April 13, 2020
The spread of the coronavirus is affecting every facet of the pharmaceutical industry — including clinical trials that are currently underway or scheduled for…
Selecting a CRO for Chronic Disease Drug Development Using Small Molecules
April 1, 2020
Though not as buzzworthy as biologics or some other trendy therapies, small molecules (i.e., organic compounds with a low molecular weight) make up the…
Beauty and the Bacteria: Mechanical Forces in a Multispecies Biofilm Colony
March 30, 2020
Diverse, abundant microbial communities are found across all of the earth’s ecosystems, from the human intestinal tract to deep water hydrothermal vents to rainforest…
Solanezumab Study Misses the Mark for the Fourth Time
March 17, 2020
Last month, American pharmaceutical company Eli Lilly ended its fourth study investigating the effectiveness of solanezumab, a potential drug therapy for people with mild cognitive…
CAR-T and CRISPR Cancer Trial Shows Promise
March 2, 2020
There is new hope for future innovation in the fast-moving field of cancer immunotherapy. Earlier this month, researchers from the University of Pennsylvania and…
Gene Therapy Innovation Strongly Encouraged by FDA with New Guidances
February 10, 2020
On January 28, 2020, the United States Food and Drug Administration (FDA) announced the release of six final guidances on gene therapy manufacturing and the…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
The Modern Quest for the Fountain of Youth
January 9, 2023
Quests for anti-aging solutions, usually the stuff of science fiction, have been revived with research into cellular reprogramming. More than 15 years ago, researchers…
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021,…
Offering Pain Relief Without Opioids, Vertex’s Sodium Channel Blocker Advances
December 12, 2022
Opioid pain relievers are highly addictive, contributing to high rates of opioid use disorder and overdose. According to the World Health Organization, opioid use…
Children with Retinitis Pigmentosa to See the World
December 7, 2022
Retinitis pigmentosa is a degenerative eye condition that slowly destroys the retina, the light-sensitive tissue at the back of the eye. For Canadian couple…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
